Explore every episode of the podcast Pharma Sessions
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Hallway Interviews with Pharma Learning Leaders | 31 Jul 2026 | 00:38:42 | |
Pharma Sessions — ACTO Client Summit: Hallway Interviews At ACTO's 2026 client summit in Boston, we pulled some incredible minds out of the hallway for quick, candid conversations about where field excellence, AI, and learning & development are headed. No scripts, no slides — just honest takes from the people doing the work. In this episode, you'll hear from six pharma L&D leaders on how AI is changing their roles, what they're doing differently at national sales meetings, the adoption challenges they're navigating, and why L&D may be the most strategically important function in any AI rollout. Timestamps:
Pharma Sessions is hosted by Jonathan Kaskey | |||
| Blockchain + AI: The Future of Healthcare Data | 09 Jul 2026 | 00:33:09 | |
What happens when you put blockchain underneath AI in healthcare? According to Archita Samant, Head of Data Strategy & Analytics for Global Vaccines at Merck — you finally solve the interoperability problem that's been holding the industry back for decades. In this episode, Jonathan sits down with Archita to unpack the real-world challenges of fragmented health data, why agentic AI demands a better data foundation than we currently have, and how blockchain could be the base layer that makes personalized medicine actually possible. They cover:
Archita also shares her winding path from pharmacist to founding a blockchain-based NFT charity platform to leading global data strategy at Merck — and her go-to karaoke song. 🎙️ Pharma Sessions is a podcast where host Jonathan Kaskey has candid conversations with interesting people across the healthcare and life sciences industry. The views expressed are those of the individuals and do not reflect the positions of their respective employers. Pharma Sessions is hosted by Jonathan Kaskey | |||
| The Question Behind the Question - Field Training with Jennifer Muszik | 08 Jun 2026 | 00:29:12 | |
What separates a good pharma sales rep from a great one? According to Jennifer Muszik, it's the ability to understand the question behind the question — the real need behind what a customer is asking. In this episode, Jonathan Kaskey sits down with Jennifer Muszik, Head of Learning & Development at Alkermes and board member of LTEN, to unpack what it takes to build world-class training programs in the pharmaceutical industry. Jennifer shares her journey from 17 years at Pfizer to leading L&D across some of pharma's most recognized organizations — and why she almost always hires people who've actually done the job they're training others to do. They get into the nuances of training new hires vs. seasoned veterans, how to engage your highest performers without making them feel attacked, and why former teachers and coaches often make the best pharma reps. Plus: a candid conversation about where AI can genuinely help — and where human connection is still irreplaceable. Topics covered:
Pharma Sessions is hosted by Jonathan Kaskey | |||
| Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce | 28 May 2026 | 00:30:07 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Frank Sorce, Chief Commercial Officer at UPM Pharmaceuticals, to share insights into the critical decisions involved in selecting contract development and manufacturing organizations (CDMOs). Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice. The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey Episode Resources:
Pharma Sessions is hosted by Jonathan Kaskey | |||
| Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury | 21 May 2026 | 00:36:42 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. Simon Chowdhury, a Consultant Medical Oncologist based at Guy's and St Thomas' NHS Foundation Trust, to talk about Open Medicine, a platform designed to take what’s inside the minds of the world’s leading oncologists and make it accessible to any clinician on a mobile phone. Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice. The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Timothy Smith on AI, Data, and Drug Discovery at Takeda | 14 May 2026 | 00:32:35 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery and development, why trust and governance are still major hurdles, and why the biggest bottleneck in pharma innovation might not be technology but people.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Lessons on Leading Through Uncertainty in Pharma | 07 May 2026 | 00:36:11 | |
In this episode of Pharma Sessions, host Jonathan Kaskey welcomes back Danie du Plessis, the first-ever guest on Pharma Sessions, for a wide-ranging conversation about what it takes to lead in medical affairs today.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Where AI Delivers Real Value in Pharma Today with Emily Lewis | 30 Apr 2026 | 00:32:51 | |
Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity.
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Emily Lewis, Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, to explore why LLMs alone won’t move medicine forward, how to build cross-functional AI literacy across your organization, and the regulatory workflows where AI will deliver impact fastest.
Disclaimer: Pharma Sessions is for informational purposes only and does not constitute medical, legal, or financial advice. Guest opinions are their own and do not reflect the views of the host or sponsors. Use of any information provided is at the listener’s own risk and does not imply endorsement of specific products or strategies. Pharma Sessions is hosted by Jonathan Kaskey | |||
| How Medical Affairs Becomes the Connector with Sonia Talwar | 23 Apr 2026 | 00:25:31 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sonia Talwar, Senior Director of Scientific Communications and Medical Information in Hematology/Oncology at Pharmacosmos Therapeutics, to discuss how medical affairs can evolve from a reactive support function into a true strategic connector.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Why Manufacturing Is the New Competitive Edge in Cell and Gene Therapy | 16 Apr 2026 | 00:32:36 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Eytan Abraham, the Chief Commercial and Technology Officer at Minaris Advanced Therapies, to dive into how pharma companies can choose the right CDMO partners, the future of cell and gene therapy manufacturing, and the hard-earned lessons behind building sustainable, high-performance organizations in one of the most complex areas of medicine.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2 | 09 Apr 2026 | 00:21:16 | |
In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable profitability and patient access.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 1 | 02 Apr 2026 | 00:31:59 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Dr. David Shulkin, President of Shulkin Solutions, to discuss what it actually takes to lead through a healthcare crisis at scale. Dr. Shulkin shares insights about the current state of U.S. public health, the intersection of policy and care delivery, the role of innovation and technology, and what must change to better serve patients.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| How AI Is Reshaping Pharma’s Commercial Operations with Punit Kumar | 26 Mar 2026 | 00:39:23 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Punit Kumar, the Executive Director of Customer Engagement for the US Enterprise Portfolio at Novartis, to dive into why execution excellence matters more than hype, how AI agents are freeing up your team from manual work to focus on high-impact insights, and the counterintuitive skill that matters most in pharma today: getting comfortable being uncomfortable.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Why Pharma products win or lose years before launch | 19 Mar 2026 | 00:32:27 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Farrell Simon, Chief Commercial Officer at Trevi Therapeutics, to discuss what commercial leadership looks like long before launch, sharing lessons from a career that spans Procter & Gamble, Pfizer, and biotech.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.
Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Building a Cancer Medtech Company the Hard Way: Shaun Bagai on Evidence, Strategy, and Growth | 12 Mar 2026 | 00:32:39 | |
Drug launches in oncology don’t succeed simply because the technology works; they succeed when the evidence is strong enough to change physician behavior. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Shaun Bagai, CEO of RenovoRx, to discuss the long and uncertain journey of building a medtech company grounded in clinical proof. From turning down medical school to leading a Nasdaq-listed oncology company, Shaun shares how physician feedback reshaped the company’s strategy, why investing in rigorous clinical trials can be a defining leadership decision, and why face-to-face relationships remain essential for market adoption in healthcare.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. Pharma Sessions is hosted by Jonathan Kaskey | |||
| How to Actually Get the Stuff You Want Approved in Pharma | 05 Mar 2026 | 00:16:21 | |
In this solo episode of Pharma Sessions, host Jonathan Kaskey breaks down what actually determines whether a new technology implementation in pharma succeeds or quietly dies in a steering committee meeting. After helping pharma companies implement nearly $200 million in new software platforms over the course of his career, Jonathan shares the patterns he’s seen again and again. Pharma Sessions is hosted by Jonathan Kaskey | |||
| How SkinPass Went From Bedside Insight to Retail Scale with Dr. Christopher Otiko | 26 Feb 2026 | 00:26:51 | |
Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side.
Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.
The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Why Drug Launches Are Won Years Before Approval with Ana Bozas | 19 Feb 2026 | 00:30:40 | |
Drug launches don’t succeed at the finish line. They succeed or fail years earlier, when teams decide what evidence they’ll generate, how they’ll publish it, and which assumptions they’ll pressure-test before it’s too late. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Ana Bozas, Director of Clinical Evidence Strategy and Scientific Communications at Vera Therapeutics, to dive into what launch readiness really means from the medical side. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Building AI Workflows That Actually Work in Pharma with Adam Mico | 12 Feb 2026 | 00:34:18 | |
Generative AI is changing analytics in pharma, but not in the way most people fear. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Adam Mico, Principal Data and Analytics Strategist at Moderna, to dive into what future-proofing really looks like when AI lowers the barrier to building dashboards, writing code, and generating insights. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Why AI Pilots Fail in Pharma, And Why Yours Won’t with Jeremy Zhang | 30 Jan 2026 | 00:34:18 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jeremy Zhang, Senior Director and Head of Data Science Solutions at Otsuka, to discuss why AI initiatives succeed or fail in pharma and why it has almost nothing to do with the technology itself. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Medical Affairs AI & Omnichannel Strategy: How to Earn Trust and Attention | 22 Jan 2026 | 00:34:40 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Sean Sheffler-Collins, Director of Scientific Communications and Content at Astellas Pharma, to discuss how Medical Affairs is evolving to meet HCPs' needs through omnichannel communication strategies, accessible and engaging scientific data, and technology-enabled solutions like digital microsites and AI analysis. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Sales Leadership Mastery: People + Tech | 15 Jan 2026 | 00:31:00 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Trevor Landry, the Executive Director of CNS Sales at Otsuka, to unpack how commercial leaders can use data and AI without losing the on-the-ground realities that drive great selling and sustainable revenue growth. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Scientific Storytelling and Omnichannel Strategy in Modern Medical Affairs | 08 Jan 2026 | 00:28:46 | |
In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Matthew Krzywosz, Director of Scientific Communications & Content at Astellas, to explore how Medical Affairs teams can create differentiated scientific narratives, use omnichannel strategy to amplify impact, and help brands stand out in highly competitive markets.\ Pharma Sessions is hosted by Jonathan Kaskey | |||
| New Direction: Career Pivots, Niche AI, and the Future of Pharma Sessions | 18 Dec 2025 | 00:18:02 | |
In this special episode of Pharma Sessions, host Jonathan Kaskey steps behind the mic solo to share the evolving vision for the podcast and the personal career shift that inspired it. What began as a show centered on medical affairs is now broadening to reflect the realities of modern pharma: commercial strategy, analytics, AI, organizational change, and the people navigating it all.
Jonathan shares the story behind his move to XSUNT and why building something meaningful again became the driving force behind his next chapter. Along the way, he reflects on what AI should be doing in pharma, why niche, domain-specific tools outperform generic platforms, and how teams can move beyond manual reporting toward real strategic impact. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Martin McLaughlin’s Four-Pillar Playbook to Launching Better, Faster, and Smarter | 04 Dec 2025 | 00:30:32 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Martin McLaughlin, former Head of Launch and Business Excellence at Takeda, to share the frameworks and lessons that help pharma organizations align people, processes, performance, and technology for success. Pharma Sessions is hosted by Jonathan Kaskey | |||
| What Happens When Pharma Starts Listening? | 13 Nov 2025 | 00:28:30 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Jens Øllgaard, Head of Customer Experience at Novo Nordisk, to discuss how forward-thinking pharma leaders are dismantling silos between medical and commercial teams, leveraging AI-driven insights, and fundamentally reimagining how field teams create value in an era of declining physician access. Pharma Sessions is hosted by Jonathan Kaskey | |||
| How Shionogi's VP Turns Data into Commercial Success | 30 Oct 2025 | 00:32:46 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Anindita (Ani) Sinha, Vice President of Commercial Operations at Shionogi, to unpack practical approaches to drive market success, from translating complex data into actionable field strategies to building effective cross-functional partnerships between commercial and medical teams. Pharma Sessions is hosted by Jonathan Kaskey | |||
| How Caitlyn Krebs Built an AI Engine That Designs Drugs 5x Faster | 16 Oct 2025 | 00:33:52 | |
In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Caitlyn Krebs, Co-Founder and CEO of Nalu Bio, to share insights about AI-driven drug development, specifically targeting the endocannabinoid system (ECS) for therapeutic development in pain management, inflammation, and women’s health. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Advice From the Frontlines of Pharma: Holistic Healthcare, The Opioid Crisis & Remote-Work in Pharma | 25 Sep 2025 | 00:31:57 | |
This episode of Pharma Sessions is much like a pharmacy - it has something for everyone. Tune in as we reflect on critical conversations hosted by Jonathan Kaskey, so far in the series. Whether it’s critical pathways into pharma careers, the opioid crisis, and work-life balance in the modern pharmaceutical industry, this recap explores it all. From transitioning into MSL roles to building diverse medical teams, guests share practical strategies for career advancement and cross-functional collaboration, offering valuable insights on medical affairs leadership, risk mitigation in pain management, and creating boundaries while working remotely.
Think of this as the playbook for pharmaceutical professionals looking to navigate industry challenges and advance their careers. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Speed is the Need: Launch strategy with Hetal Patel | 11 Sep 2025 | 00:27:08 | |
In this episode of Pharma Sessions, host Jonathan Kaskey talks with Hetal Patel, VP of Medical Affairs at Celltrion USA, about building a medical affairs function from the ground up while launching multiple drugs. Sounds like a hot pot of pressure, decision-making and sleepless nights, doesn't it? Well, don’t let this intimidate you just yet. From transitioning out of big pharma to scaling systems with limited resources, Hetal shares practical strategies for thriving in high-pressure launch environments and how to do so without burning out. Pharma Sessions is hosted by Jonathan Kaskey | |||
| Beyond the Clinic: A Conversation with Dr. Adam Laitman, Director of Medical Affairs for Salix Pharmaceuticals | 29 May 2025 | 00:28:18 | |
In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Adam Laitman about his unconventional path to becoming a medical director in the pharmaceutical industry. Dr. Laitman shares insights from his career transition from medical school to industry, highlighting the impact of his background in marketing and editorial work. The discussion covers the various career opportunities within medical affairs, the importance of diverse educational backgrounds, and the potential be... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Breaking into Pharma with Emet Anceaume, Director of Field Medical Affairs at Immunovant | 14 Apr 2025 | 00:30:50 | |
In this episode of Pharma Sessions, host Jonathan Kaskey discusses career transitions into the pharmaceutical industry, specifically focusing on roles like Medical Science Liaisons (MSLs). The guest, Emet Anceaume is the Director of Field Medical Affairs at Immunovant. Emet is a pharmacist by training. She shares her insights on the importance of transferable skills, the challenges and strategies for breaking into pharma, and the distinction between working for big pharma and small biot... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Everyday is a New Puzzle with Vince Turner, Dir. Development Operations, Kite Pharma | 17 Mar 2025 | 00:36:40 | |
In this episode of Pharma Sessions, hosted by Jonathan Kaskey, Vince Turner shares his insights on integrating creativity into operational environments. The discussion covers Vince's career journey from financial services to pharma, and his operational strategies at Kite. Emphasis is placed on the importance of creativity in solving challenges, the value of building strong relationships, and empowering team members. And stay to the end for the buttermilk pancakes recipe (courtesy of Mel... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Combining Tech and Pharma for Public Health with Paul Howe, COO of Protega Pharmaceuticals | 28 Feb 2025 | 00:31:58 | |
In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health. They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks. Introduction and startling data on prescription abuse Welcome and guest introduction Paul Howe's breakfast routine&nb... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Bursting the Med Affairs Bubble with Dr. Samin Saeed, VP Early Medical Pipeline at GSK | 03 Dec 2024 | 00:30:06 | |
Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional Collaboration In this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of industry experience currently at GSK. They discuss the need for medical affairs to move beyond speaking only to themselves and to engage more openly with other functions within pharmaceutical organizations. Dr. Saeed advocates for a collaborative approach and shares h... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Why Pharma needs Chiefs of Staff with Steve Cirillo-Thompson | 11 Oct 2024 | 00:34:47 | |
In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shares his unconventional journey into the medical affairs space, transitioning from political science to consulting, and eventually stepping into various Chief of Staff roles at some of the leading pharmaceutical companies like Shire, Takeda, Abbvie and Ki... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Achieving Work-Life Integration in Med Affairs with Jen Mohawk | 16 Aug 2024 | 00:30:14 | |
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics. They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires. Jen shares her journey from academia to the biopharma industry, driven by her pursuit of a sustainable work-life balance. They delve into practical strategies for integrat... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Future Proofing Medical Affairs with Stephanie Hunter-Banks | 10 Jun 2024 | 00:35:52 | |
Future Proofing Medical Affairs: A Conversation with Stephanie Hunter Banks In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evolving healthcare ecosystem. Stephanie shares insights on creating a culture of innovation, leveraging big data and AI, and fostering collaboration within pharma companies. She reflects on her own career journey from pharmacy to leading learning ... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Kaskey's Hierarchy of Needs for Medical Affairs with guest Stephen Dodge, SVP of Medical Affairs for Madrigal Pharmaceuticals | 09 Apr 2024 | 00:38:06 | |
Kaskey's Hierarchy of Needs in Medical Affairs: Steering towards Successful Product Launches This episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position. Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies. The discussion t... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Using Regulatory Processes to Enhance Patient Care: A Conversation with Lars Dreesmann | 06 Mar 2024 | 00:38:33 | |
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care. They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies. Lars shares his transition from academia to the pharmaceutical industry, the thrill ... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Innovation in Medical Affairs: Embracing AI for Success with Scott Thompson | 05 Feb 2024 | 00:32:55 | |
This episode is sponsored by Acceleration Point. Pharma Sessions is hosted by Jonathan Kaskey In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs. Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements. Scott encourages experimentation with secure, customized AI tools to improve output. He outlines a case study where AI imp... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Small Team, Big Impact: Life as The First MSL in a Biotech Startup with Orlando Granado-Balaez | 22 Jan 2024 | 00:30:18 | |
Life is different at a biotech. But is that a good thing? Like so much in life, the answer is, "it depends." On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies. He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team. Orlan... Pharma Sessions is hosted by Jonathan Kaskey | |||
| The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs | 02 Jan 2024 | 00:47:27 | |
The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs In this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health. They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function. On the other hand, they stress the benefits of prioritizing good quality sleep for enhanced p... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Global Launch Excellence: Navigating Local and Global Challenges in Pharma with Jose Borbolla-Escoboza | 12 Dec 2023 | 00:29:32 | |
In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US. Together, they explore the multifaceted process of global launch preparation and the crucial role of global in facilitating tools for local country launches.&n... Pharma Sessions is hosted by Jonathan Kaskey | |||
| The Art and Science of Negotiation in Medical Affairs | 30 Oct 2023 | 00:32:19 | |
In this episode of "Pharma Sessions," host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs. Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen. Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness. Megan emphasizes the significance of maintaining a positive relationship with complian... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Gene Therapy Breakthroughs: Exploring the Crucial Role of Medical Affairs with Dr. Huma Qamar | 03 Oct 2023 | 00:35:03 | |
In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc. With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five things you'll learn: 1. The importance of patient-centered outcomes re... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Unlocking Potential: Hidden Data and Disparities in Clinical Trial Participation | 12 Jul 2023 | 00:36:01 | |
Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry. Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training. Top 5 learnings from the episode: The critical need for data shar... Pharma Sessions is hosted by Jonathan Kaskey | |||
| 4 Medical Affairs Hacks for Time Management | 23 Jun 2023 | 00:34:39 | |
In this episode, host Jonathan Kaskey invites Patrina Pellet to discuss effective time management strategies for medical professionals. From calendar audits to time blocking, Pellet shares valuable insights on how to optimize your daily schedule, prioritize your tasks and avoid feeling burnt out. Discover the power of color-coding and task tracking to manage your workload efficiently and achieve your goals. Tune in now to master the art of time management and increase you... Pharma Sessions is hosted by Jonathan Kaskey | |||
| The 4 R's of Medical Information with Tim Fish | 22 May 2023 | 00:25:29 | |
We are excited to bring you the latest episode of our podcast series where we tackled the vital role of medical information in the healthcare industry. Tim Fish is the Sr. Director of Medical Information, Knowledge Management, Med/Promo Review, Scientific Training & Development at Alkermes. Tim has been in the medical information role for 15 years and shared valuable insights on the importance of receiving and responding to inquiries, reviewing content, and researching answers in medical... Pharma Sessions is hosted by Jonathan Kaskey | |||
| Improving Diversity in Clinical Trials: Challenges and Solutions | 04 May 2023 | 00:22:16 | |
This episode is the second in Pharma Sessions' series of conversations about clinical trial diversity. The first episode was with a former pharma executive turned clinical trial consultant. In this episode we share a different, more community oriented perspective. Renarda Jones is a clinical trial professional with over 20 years’ experience in clinical research., mainly in Cancer and Alzheimer’s disease research. Starting as a research assistant, working her way up to study coordinator and cl... Pharma Sessions is hosted by Jonathan Kaskey | |||